This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wellenreuther, R. Articles by von Deimling, A. Search for Related Content PubMed PubMed Citation Articles by Wellenreuther, R. Articles by von Deimling, A.

American Journal of Pathology, Vol 146, 827-832, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma

R Wellenreuther, JA Kraus, D Lenartz, AG Menon, J Schramm, DN Louis, V Ramesh, JF Gusella, OD Wiestler and A von Deimling
Department of Neuropathology, University of Bonn, Germany.

There is evidence from cytogenetic and loss of heterozygosity studies for the involvement of a tumor suppressor gene on chromosome 22 in the formation of meningiomas. Recently, the NF2 gene, which causes neurofibromatosis type 2 and which is located in the affected region on chromosome 22, has been identified. A previous study on 8 of the 17 exons of the NF2 gene described mutations in 16% of meningiomas. We have analyzed the entire coding region of the NF2 gene in 70 sporadic meningiomas and identified 43 mutations in 41 patients. These resulted predominantly in immediate truncation, splicing abnormalities, or an altered reading frame of the predicted protein product. Although there was no evidence for distinct hotspots, all mutations occurred in the first 13 exons, the region of homology with the filopodial proteins moesin, ezrin, and radixin. The association of loss of heterozygosity on chromosome 22 with mutations in the NF2 gene was significant. These data suggest that NF2 represents the meningioma locus on chromosome 22. NF2 mutations occurred significantly more frequently in fibroblastic meningioma (70%) and transitional meningioma (83%) than in meningiothelial meningioma (25%), thus indicating a differential molecular pathogenesis of these meningioma variants.

This article has been cited by other articles:

				D. Krex, B. Klink, C. Hartmann, A. von Deimling, T. Pietsch, M. Simon, M. Sabel, J. P. Steinbach, O. Heese, G. Reifenberger, et al. Long-term survival with glioblastoma multiforme Brain, October 1, 2007; 130(10): 2596 - 2606. [Abstract] [Full Text] [PDF]

				M E Baser and T Y Poussaint Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma J. Med. Genet., March 1, 2006; 43(3): 285 - 287. [Abstract] [Full Text] [PDF]

				N. Comtesse, A. Zippel, S. Walle, D. Monz, C. Backes, U. Fischer, J. Mayer, N. Ludwig, A. Hildebrandt, A. Keller, et al. Complex humoral immune response against a benign tumor: Frequent antibody response against specific antigens as diagnostic targets PNAS, July 5, 2005; 102(27): 9601 - 9606. [Abstract] [Full Text] [PDF]

				M E Baser, L Kuramoto, R Woods, H Joe, J M Friedman, A J Wallace, R T Ramsden, S Olschwang, E Bijlsma, M Kalamarides, et al. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 J. Med. Genet., July 1, 2005; 42(7): 540 - 546. [Abstract] [Full Text] [PDF]

				P. G. Buckley, C. Jarbo, U. Menzel, T. Mathiesen, C. Scott, S. G. Gregory, C. F. Langford, and J. P. Dumanski Comprehensive DNA Copy Number Profiling of Meningioma Using a Chromosome 1 Tiling Path Microarray Identifies Novel Candidate Tumor Suppressor Loci Cancer Res., April 1, 2005; 65(7): 2653 - 2661. [Abstract] [Full Text] [PDF]

				D. Mihaila, J. A. Gutierrez, M. L. Rosenblum, I. F. Newsham, O. Bogler, and S. A. Rempel Meningiomas: Analysis of Loss of Heterozygosity on Chromosome 10 in Tumor Progression and the Delineation of Four Regions of Chromosomal Deletion in Common with Other Cancers Clin. Cancer Res., October 1, 2003; 9(12): 4435 - 4442. [Abstract] [Full Text] [PDF]

				W. Mueller, C. Hartmann, A. Hoffmann, W. Lanksch, J. Kiwit, J. Tonn, J. Veelken, J. Schramm, M. Weller, O. D. Wiestler, et al. Genetic Signature of Oligoastrocytomas Correlates with Tumor Location and Denotes Distinct Molecular Subsets Am. J. Pathol., July 1, 2002; 161(1): 313 - 319. [Abstract] [Full Text] [PDF]

				J. Bostrom, B. Meyer-Puttlitz, M. Wolter, B. Blaschke, R. G. Weber, P. Lichter, K. Ichimura, V. P. Collins, and G. Reifenberger Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic Meningiomas Am. J. Pathol., August 1, 2001; 159(2): 661 - 669. [Abstract] [Full Text]

				D. H. Gutmann, A. C. Hirbe, and C. A. Haipek Functional analysis of neurofibromatosis 2 (NF2) missense mutations Hum. Mol. Genet., July 1, 2001; 10(14): 1519 - 1529. [Abstract] [Full Text] [PDF]

				J. Lasota, J. F. Fetsch, A. Wozniak, B. Wasag, R. Sciot, and M. Miettinen The Neurofibromatosis Type 2 Gene Is Mutated in Perineurial Cell Tumors : A Molecular Genetic Study of Eight Cases Am. J. Pathol., April 1, 2001; 158(4): 1223 - 1229. [Abstract] [Full Text] [PDF]

				K. Ueki, C. Wen-Bin, Y. Narita, A. Asai, and T. Kirino Tight Association of Loss of Merlin Expression with Loss of Heterozygosity at Chromosome 22q in Sporadic Meningiomas Cancer Res., December 1, 1999; 59(23): 5995 - 5998. [Abstract] [Full Text] [PDF]

				R. G. Weber, J. Bostrom, M. Wolter, M. Baudis, V. P. Collins, G. Reifenberger, and P. Lichter Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression PNAS, December 23, 1997; 94(26): 14719 - 14724. [Abstract] [Full Text] [PDF]